Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2019 Nov 21;14(11):e0224749. doi: 10.1371/journal.pone.0224749

The impact of “male clinics” on health-seeking behaviors of adult men in rural Kenya

Justine Dowden 1,¤a, Ivy Mushamiri 2, Eric McFeely 1,¤b, Donald Apat 3, Jilian Sacks 1,¤c, Yanis Ben Amor 1,*
Editor: Kwasi Torpey4
PMCID: PMC6872147  PMID: 31751377

Abstract

Background

In most parts of the world, men access health services less frequently than women, and this trend is unrelated to differences in need for services. While male involvement in healthcare as partners or fathers has been extensively studied, less is known about the health-seeking behavior of men as clients themselves. This interventional research study aimed to determine how the introduction of male-friendly clinics impacted male care-seeking behavior and to describe the reasons for accessing services among men in rural Kenya.

Methods and findings

We questioned men to assess utilization and perceptions of existing health clinics, then designed and evaluated a “male clinics” intervention where dedicated male health workers were hired for one year to offer routine, free services exclusively to men within existing healthcare facilities. Results were compared between data from Male Clinics in specific health facilities, the same facilities concurrently, nearby control facilities concurrently, and intervention facilities historically.

Costs of services, distance to facilities, and quality of care were the main barriers to healthcare access reported. The number of total visits was significantly higher than control groups (p<0·0001). In the intervention group, 18·6% of visits were for a checkup compared to almost none in control groups. The most common diagnoses overall were upper respiratory tract infections, malaria and injury. A major limitation of this study is the non-comparability in information captured using the Male Clinic registers compared to control registers.

Conclusions

Costs and quality of services deter men from seeking healthcare. The introduction of male-friendly health services could encourage men to seek preventive care and increase service uptake.

Introduction

Access to free services remains a significant challenge to receiving quality healthcare in resource-limited settings and is a cause of underutilization of healthcare by men [1]. While male involvement in healthcare as partners or fathers has been extensively studied in the developing world context [26], far less emphasis has been placed on the health-seeking behavior of men as clients themselves. Often, studies analyzing men’s attendance at rural health clinics in low-income settings have focused on their involvement in programs related to maternal and child health, especially programs to decrease mother-to-child transmission of HIV [5, 710]. However, far fewer programs and research initiatives in low-income countries focus on men exclusively as independent agents seeking access to healthcare [11]. This is problematic because seeking care is often seen as counter-normative for men, particularly in patriarchal societies, and is instead an activity viewed as particularly necessary for women and children [1214]. Furthermore, clinics are often viewed as “female spaces,” because females usually make up most of the patient and caregiver population in these settings [12]. As a result, it is common for men to only seek care during emergencies or in the later stages of preventable illnesses [1517].

The “male clinics” intervention aimed to narrow this gap in male health-seeking behavior in western Kenya, where services are primarily accessed by women and children. Since services are also mostly provided by female health workers, the research hypothesis of the qualitative study was that men’s concerns over confidentiality and views about gender norms are barriers to their uptake of services at clinics. Preliminary research was conducted to learn the reasons local men were not more frequently visiting clinics, and subsequently a “male clinics” (MCs) intervention was implemented to address the identified challenges. In viewing men as patients in their own right and providing a space to meet their individual needs confidentially and sensitively, we sought to create a more enabling clinical environment with the goal of ultimately increasing men’s uptake of health services. The paper highlights the benefit of a general health approach, rather than a disease-based approach, to engage men in health services.

By appointing male health workers and directing services to men alone in a separate area within a clinic, we aimed to create an incentive for men to seek care. The hypothesis was that a male-friendly space would improve men’s health-seeking behavior and increase uptake of care by reducing cultural barriers, particularly in the case of stigmatized or sensitive conditions. Also, targeted services were intended to improve efficiency as an added incentive, since patients are often required to wait a long time for care at clinics in resource-limited settings.

Materials and methods

Study area

The study site was located in Sauri, Siaya county in western Kenya within a Millennium Villages Project (MVP) site. The MVP context has been described previously [1819]. Sauri contains 11 villages and the total catchment population for the health facilities is 73,089. Adult men over 18 years of age make up approximately 13·3% (n = 9,713) of the total population [20]. There are 10 health facilities, one of which offers free care for all services to men. In other clinics, care is only completely free for pregnant women and children under five; some basic care is free for all. Only Ramula and Nyawara intervention clinics offered free voluntary medical male circumcision, while the others did not. Both clinics were low volume sites.

Preliminary focus groups and trial

In the first phase of this study (October-December 2013), a qualitative questionnaire was fielded with 124 men over 18 years old in Sauri district to assess utilization and perceptions of local clinics. MVP staff led recruitment. Community Health Workers (CHWs) spread awareness of the questionnaire during home visits and others recruited by word-of-mouth during community events such as “men’s health days.” A convenience sample was established by selecting men from communities with differing proximities to clinics.

Kenyan data clerks who worked for MVP were trained in survey administration. The questionnaire was available in English, Swahili and Luo. The interviewers conducted structured focus group discussions and individual interviews, including questions about frequency of and reasons for past clinic visits, along with open-ended questions about reasons men would visit a clinic, obstacles preventing men from accessing care and possible improvements to the health centers.

Following the focus groups, MVP conducted a one-month pilot MC at two clinics in Sauri. As part of this pilot, we organized a “men’s health day,” which was a sensitization day involving a male nurse at each clinic providing education to male visitors primarily about sexual health, as per focus group recommendations. Men were then seen by a male clinical officer hired by MVP for individual consultation at a unit separate from the clinic that caters to women and children; services were free.

Establishment of male clinics

Following feedback from the one-month pilot, we designed an MC intervention, hiring two dedicated male health workers to be stationed in a designated area within existing healthcare facilities to offer free services exclusively to male patients on a specific day of every month. We carried out this intervention for 12 months at five local health facilities to determine the impact of a male-friendly clinic on male attendance rates at the health centers, and its impact on specific health-seeking behaviors associated with free simplified access.

Intervention activities

The two male health workers were stationed for several daytime hours once per month at five clinics—Lihanda, Marenyo, Nyawara, Ramula, and Sauri—in an isolated area within each clinic to ensure privacy. During consultations, the health workers filled out a register with basic information about the visit, but no identifiable information was recorded to comply with ethical review board requirements (S1 Appendix).

The health workers at the MC offered a range of services for common ailments (Table 1). Preventive care was also available, including HIV testing, STI screening, and blood pressure checks, and men were referred if necessary.

Table 1. Common ailments that Male Clinics were equipped to treat.

Malaria
URTI
STI
Enteric fever
Neuritis
Gastroenteritis
Fungal infections
Hypertension
Diabetes
Epilepsy
Arthritis
Allergy
Injury/trauma
Sexual dysfunction
UTI
Peptic ulcer disease
Pneumonia, asthma, pleurisy/LRTI
Dental problems (referral)
Myalgia
Cellulitis
Other

Evaluation design

Patient registers were collected from clinics in four groups: 1) “Intervention,” which was data collected on MC days, 2) “Concurrent control at intervention clinics,” which was data from the same clinics where the intervention took place during the same time period, but on days when the MC did not occur, 3) “Concurrent control at different clinics,” was data from five clinics which did not have MCs during the same time period as the intervention, and 4) “Historic control,” which was data from intervention clinics two years prior from November 2012 to November 2013.

MCs were open during the same hours as control clinics.

Because no identifiable information was collected, the unit of analysis was visits, not people, with the exception of the age variable. Median age was calculated by excluding the subsequent visits of those who had visited MCs more than once to avoid double counting.

Outcomes of interest and measurement

Outcomes of interest were divided into five groups: reason for visit, service utilization, type of diagnosis, quality of care, and the “male-friendliness” of the MCs. We aimed to understand how many visits were made by sick patients compared to healthy patients coming for check-ups, whether uptake of services increased when an MC was offered, for which ailments men sought care, whether MC clinicians appropriately diagnosed patients, and whether patients were visiting MCs for sensitive reproductive health issues.

The reason for visit was recorded as either “check-up” or “sick,” as per MC clinician assessment, and was compared to the control groups. The MC clinician also recorded whether each visit was a first or follow up visit.

To measure service utilization, we calculated the number of visits on a monthly basis as a proportion of the total male population in the catchment area and compared the number of visits at MCs with the number of visits in all control groups. We also calculated the proportion of total visits that occurred monthly.

Quality of care was measured by assessing how frequently the MC clinician provided proper treatment for six common diagnoses that corresponded with standardized treatments (Table 2). We chose these ailments because they had a finite number of treatment options in this particular setting.

Table 2. Common diagnoses at Male Clinics and corresponding standardized treatments.

Diagnosis Treatment
Diabetes Metformin
Hypertension Hydrochlorothiazide
Epilepsy Anti-epilepticsa
Fungal infection Anti-fungalsb
Peptic Ulcer Disease (PUD) Omeprazole
Malaria Artemether/Lumefantrine

a Includes phenobarbital, diazepam, tegretol

b Includes clozole, griseofulvin, gentian violet

Also, the dates of study collection among the concurrent control at different clinics group was limited to July-November 2015, while data was collected from November 2012-November 2013 in the historic control group and November 2014-November 2015 in the remaining two groups.

Statistical analysis

Statistical analyses were conducted using SAS 9·4, STATA 14·1, SPSS 22·0, and MS Excel 2016 software. The preliminary questionnaire was analyzed using SPSS after combining open-ended responses into similar categories. To test for a difference in the number of visits made as a proportion of the total male population in the catchment area by group as a measure of service utilization, a two-sample t-test was conducted for each intervention-control group comparison and an ANOVA test was used to compare across groups. Bonferonni adjustments were made to account for multiple comparisons (alpha/3). To assess correct treatment for diagnosis by group as a measure of quality of care, a chi-square analysis was conducted comparing the proportion of diagnoses that were correctly treated by intervention or control group. Quality of care was measured by calculating the proportion of correct treatments for each diagnosis in the intervention group and was assessed using chi-square tests with a Bonferonni adjustment to account for multiple comparisons. A chi-square test was also used to assess the proportion of visits that were check-ups, and the proportion of times a provider-initiated testing and counseling (PITC) was conducted among patients who did or did not know their HIV status.

Finally, we investigated how many men were diagnosed with STIs and/or sexual dysfunction at MCs compared to the control groups, with the expectation that men were more likely to want to address these sensitive issues in an MC environment versus a regular clinic. A chi-squared test was used to compare the proportion of diagnoses that were STIs and sexual dysfunction between the intervention group and all control groups.

Results

Preliminary questionnaire findings

Cost of services, distance, and cost of travel were the most commonly reported barriers to visiting clinics among men who had never visited a facility (n = 112). Also, only 52·9% (n = 63) of men overall reported satisfaction with healthcare providers. Common suggestions for improvements to providers included being more respectful (32·7%, n = 33) and reducing wait times (23·8%, n = 24). Participants’ most common fears about visiting facilities included a lack of confidentiality (35%, n = 7), time delays and inefficiency (20%, n = 4), and concerns about HIV testing (10%, n = 2) (Table 3). Additionally, 86·3% (n = 107) of respondents felt that women were most likely to use health facilities; just 2·4% (n = 3) said adult men were most likely to do the same. This feedback informed the design of MCs.

Table 3. Select preliminary questionnaire findings.

Total number of responses %
Satisfaction with health providers 119
Satisfied with providers’ competency 65 54.6%
Satisfied overall 63 52.9%
Satisfied with provider’s attitudes 55 46.2%
Believe improvements could be made to providers 116 93.5%
Yes 104 89.7%
No 12 10.3%
Suggestions for improvement to providers 135
More respectful 40 29.6%
More timely 30 22.2%
More staff 25 18.5%
Staff provide medication 15 11.1%
Better trained 13 9.6%
Staff provide better urgent care 4 3.0%
Ward for men 2 1.5%
Staff provide free care 2 1.5%
Improved hygiene 1 0.7%
More male providers 1 0.7%
Less corrupt 1 0.7%
Mortuary 1 0.7%
Common reasons men visit health facilities 121
Treatment during illness (usually severe) 80 66.1%
HIV services 26 21.5%
Malaria 6 5.0%
Health information/general check-ups 3 2.5%
Circumcision 3 2.5%
Accompanying others 2 1.7%
First aid 2 1.7%
STI services 1 0.8%
Overall health 1 0.8%
Obstetrics 0 0.0%
Family planning 0 0.0%
Common fears about seeking care among men with fears 25
Not confidential 7 28.0%
Delays / inefficiency 4 16.0%
Scared of HIV test/result 2 8.0%
Fear of blood draws / injections / taking medication 2 8.0%
Service will be inaccurate / incorrect 2 8.0%
Harshness of how staff treat patients 1 4.0%
Expense 2 8.0%
Largest barrier to visiting health facility among men who have never visited a facility 112
Cost of services 74 66.1%
Distance 15 13.4%
No time 12 10.7%
Cost of transport 4 3.6%
No barriers 3 2.7%
Not helpful 1 0.9%
Fear of HIV test 1 0.9%
Attitude of health staff 1 0.9%
Majority of staff women 1 0.9%

Male clinics findings

Demographics

The median age of MC patients was 32. Men who visited the MC multiple times were included in this calculation only for their first visit; ages of patients coming for subsequent visits were excluded. The ages ranged from 15 to 80-years-old. Many men were farmers as agriculture is the main economic activity in the region. Most likely the younger patients were often students at a nearby university.

Number of visits

Comparison by ANOVA revealed that the number of visits to MCs as a proportion of the total catchment population was higher in the intervention group than the number of visits to a clinic (by population) made by men in any control group (p < .0001).

The mean visits (and standard deviation) for each group were 3·77 (1·70) for the concurrent control at different clinics group, 21·26 (15·89) for the historic control group, 26·37 (19·32) for the intervention group, and 20·15 (15·35) for the concurrent control at intervention clinics group (Fig 1). Additionally, out of 571 MC visits, half (50·1%, n = 286) were re-visits (Table 4).

Fig 1. Monthly visits to clinics as a proportion of total male population in catchment area by intervention group (ANOVA).

Fig 1

Table 4. Proportion of repeat visits to Male Clinics.

Clinic Total visits to intervention clinics Amount of re-visits to Male Clinics Re-visits to Male Clinics as a proportion of total visits
Lihanda 182 95 52.2%
Marenyo 107 52 48.6%
Nyawara 67 20 29.9%
Ramula 83 33 39.8%
Bar Sauri 132 86 65.2%
Total 571 286 50.1%

Reasons for visits

The reason for visit was recorded as either “checkup” or “sick.” In all control groups combined, there were just 34 checkups recorded, 1·2% of total visits in those group, and zero in the concurrent control at different facilities group. Conversely, 20·2% (n = 115) of visits in the intervention group were for checkups instead of in response to a health problem.

Most frequent diagnoses

The most common diagnoses across all groups were upper respiratory tract infections (URTI), malaria and injury. The intervention group had the lowest proportion of URTI diagnoses (20·6%, n = 136). On average, 26·2% (n = 1066) of visits resulted in a URTI diagnosis in all groups. For malaria, the proportion was lowest (20·6%, n = 136) in the intervention group. Injuries were diagnosed at 9·8% (n = 65) of MC visits (Table 5). During checkups in the intervention group (n = 115), the top two diagnoses were URTI (15·7%, n = 18) and hypertension (12·2%, n = 16).

Table 5. Frequency of diagnoses in all groups.

Diagnosis Intervention group Concurrent control at different facilities group Historic control group Concurrent control at intervention facilities group
n % n % n % n %
Allergy 20 3.0% 5 0.7% 12 1.5% 12 0.6%
Arthritis 14 2.1% 9 1.3% 8 1.0% 14 0.7%
Cellulitis 0 0.0% 9 1.3% 11 1.4% 39 2.1%
Dental 7 1.1% 29 4.1% 6 0.7% 9 0.5%
Diabetes 11 1.7% 0 0.0% 4 0.5% 13 0.7%
Enteric Fever 23 3.5% 16 2.2% 5 0.6% 2 0.1%
Epilepsy 10 1.5% 4 0.6% 9 1.1% 23 1.2%
Fungal infection 17 2.6% 12 1.7% 17 2.1% 13 0.7%
Gastroenteritis 27 4.1% 26 3.6% 22 2.7% 63 3.4%
Hypertension 25 3.8% 12 1.7% 5 0.6% 26 1.4%
Injury/Trauma 65 9.8% 67 9.4% 64 7.9% 189 10.1%
Malaria 136 20.6% 155 21.7% 236 29.1% 514 27.4%
Missing 30 4.5% 2 0.3% 18 2.2% 37 2.0%
Myalgia 0 0.0% 16 2.2% 20 2.5% 78 4.2%
Neuritis 14 2.1% 1 0.1% 4 0.5% 2 0.1%
Other 64 9.7% 95 13.3% 81 10.0% 218 11.6%
Pneumonia, Asthma, Pleurisy/LRTI 5 0.8% 9 1.3% 29 3.6% 35 1.9%
PUD 25 3.8% 19 2.7% 10 1.2% 21 1.1%
Sexual Dysfunction 2 0.3% 0 0.0%   0.0%   0.0%
STI 14 2.1% 23 3.2% 24 3.0% 43 2.3%
URTI 136 20.6% 190 26.6% 224 27.6% 516 27.5%
UTI 46 7.0% 18 2.5% 20 2.5% 45 2.4%
Total 661   715   811   1875  

Reproductive health services

We investigated how many men were diagnosed with STIs and/or sexual dysfunction at MCs compared to the control groups in pursuit of the “male-friendly” hypothesis that men were more likely to want to address these sensitive issues in an MC environment versus a regular clinic. We compared the number of STI diagnoses in control groups with the intervention group. STI diagnoses were the result of 2·6% of MC visits (n = 14), 3·6% of visits in the “concurrent control at different facilities” group, 3·3% in the historic control group, 2·6% in the “concurrent control at intervention facilities” group, and 2·97% (n = 90) of visits in all control groups combined. Differences in STI diagnoses across all groups were not statistically significant (p = 0·5043).

Sexual dysfunction was a recorded diagnosis at two visits in the intervention group and at zero visits in all control groups. The small number is not enough to draw a meaningful conclusion.

Within the intervention group, 25 syphilis screenings occurred, of which five were positive. After malaria, PITC for HIV was the second most common test at all intervention clinics except for Ramula, where it was the most common. PITC was offered 184 times and made up 27·4% of all tests (n = 672). There was no statistically significant difference in PITC offering by clinic (p = 0·11).

Quality of care

Rates of correct treatment for diagnosis by group varied significantly. The intervention group had the smallest proportion of correct treatments by diagnosis (82·9%, n = 165) compared to all control groups (p<0·0001). This figure did not vary greatly among control groups, ranging from 93·3% in the historic control group to 90·9% in the “concurrent control at different clinics” group. Out of six common diagnoses, malaria and epilepsy were treated correctly 100% and 95% of the time respectively in the intervention group while fungal infections were treated correctly 25% of the time (Table 6). The proportion of correct treatment for diagnosis in the intervention group ranged from 25·0% (n = 3) for fungal infections to 100% (n = 10) for epilepsy.

Table 6. Proportion of correct treatments for select diagnoses at Male Clinics.

Number of correct treatments Percent correct Number of incorrect treatments Percent incorrect
Malaria 129 94.9 6 10.2
Fungal infections 3 25.0 9 75.0
Hypertension 7 36.8 12 63.2
Diabetes 2 50.0 2 50.0
Epilepsy 10 100.0 0 0.0
Peptic ulcer disease 14 73.7 5 26.3
Missing 31

The proportion of times PITC was offered in the intervention group was high for patients who did not know their HIV status (90·3%, n = 149), compared to those who already knew their HIV status (8·5%, n = 34), p<0·0001.

Discussion

Women regularly access health services, either for their own health or for their children. In contrast, in most parts of the world, men do not access health services as frequently. This phenomenon is unrelated to a difference in need for services [12]. Most health programs in low-resource settings are designed for women and children, with few exceptions focusing on men as clients in their own right [2122]. Based on findings from our early focus group discussions, cost of services, distance to the facility and associated cost of transport, as well as quality of services were reported as the main barriers to seeking care. We also found that men sometimes do not access health services because they associate care-seeking behavior with weakness, feel it is not worth missing a day’s salary, or believe health centers to be places for women and children that are not catered to their direct needs. These findings are consistent with previous research [12, 2325]. As a result, many men access health services primarily for curative care [2627] and at an advanced stage of a health issue [1617].

In response, we launched MCs to address men’s concerns and to provide services tailored to their needs, with the goal of improving health-seeking behavior. While MCs could not directly respond to the issues reported during focus groups associated with distance to the facility or cost of transport, MCs did directly addressed the problems of service costs and wait times.

The number of total visits at MCs was significantly higher compared to regular clinics across all control groups. Additionally, among visits where the reason was known, more men in MCs accessed services for a check-up (20·2% of the time) compared to all control groups (1·2% of visits). The high rate of utilization of preventive care at MCs is important given the general trend of low uptake of health resources among men, particularly at early stages of a health issue. In MCs, the amount of check-ups might indicate that more men would likely access preventive health services in the context of MCs where all services are free—not just for pregnant women and children—and when the wait time is short.

The largest number of visits within the intervention group were to Sauri clinic. This could be explained by the fact that services at Sauri were already free in addition to the MCs. Also, unlike other facilities in the area, Sauri clinic is closest to the referral hospital, was recently constructed, and had a large staff with good management. Conversely, other clinics sometimes experienced commodities stock-outs and were smaller.

We also noted that half of MC visits were from men who had accessed services at MCs before. This is a desired positive outcome for health facilities that want to monitor progress of their patients in a context where most male patients fail to return for follow-ups, or want their patients to come in the early stages of any ailment. We could not compare this result to control groups because these data were not captured in general outpatient services.

Close to 10% of MC visits were from men who presented with an injury, which is about the same proportion as in all control groups. This is notable considering that MCs were only held once monthly, but the proportion was similar to control groups where patients could get services every day. This may indicate that these patients did not visit the regular clinic on the day of the injury, but waited for MC as a way of minimizing their costs and wait time for services.

Our analysis demonstrated that the quality of care, measured as the percentage of adequate treatment for six common diagnoses, was the lowest in MCs as compared to control groups, though correct prescribing was high across all groups. This could be due to myriad factors, including potential recording bias in the control facilities—only data from entries recording both diagnosis and treatment provided could be used for our analysis, which was a subset of all the entries in the registers that are often poorly filled out—potentially limited commodity availability in the MCs leading to unavailability of correct medicines and small sample size for certain conditions leading to disproportionately high rates of incorrect treatment (e.g. n = 19 total treatments for hypertension and n = 4 for diabetes).

During MC sessions, PITC was accepted at over 90% (n = 149) of visits where patients reported not knowing their HIV status. This is an added benefit of MCs, which could assist in reaching the first goal of the UNAIDS 90-90-90 targets [28]. In control registers, data on which visits resulted in PITC are available but whether the patient had existing knowledge of his status was not reported.

Additionally, rates of STI screening were not significantly higher at MCs compared to controls, despite the private setting available. The positivity rate following STI screening at MCs was the same as in control groups, which is expected since the male population is comparable across groups.

Finally, some practices following the inception of MCs contradicted results from the focus group discussions. For example, when asked for common reasons men would go to a clinic, 3·2% (n = 4) said for check-ups. Conversely, 20·2% of visits to MCs were for check-ups, indicating that perhaps there is greater demand for preventive services than had been anticipated.

Future research could consider investigating whether the gender of a provider impacts uptake and types of services. If men prefer male providers for services similar to those provided in MCs, uptake might be hindered by the dearth of male service providers at lower tiers of the health workforce [29]. Further research could also explore the impact of no-cost services on male health-seeking behavior.

Limitations

The main limitation of this study is the difference in information captured using the MC registers compared with control registers. We developed the MC registers to collect all information needed to demonstrate impact, but similar information was not always available in existing national registers which was the source of information for the control populations. As a result, “services offered,” such as blood pressure or STI screenings, tests given, or revisits were not systematically recorded in the control data. Additionally, registers are commonly lost in clinics, and are typically not kept very long once they are full, which made collection of historic data challenging. For example, records from the “concurrent control at different clinics” group were only available for part of the needed duration—from July 2015-November 2015 instead of November 2014-November 2015. Second, for confidentiality purposes, we did not collect personal identifiers. As a result, only distinct visits were tracked because it was not possible to track individual patients. This prevented us from distinguishing whether a revisit at MC was for continuing treatment of an existing illness or for a new ailment. Third, the algorithm to determine quality of care only took into consideration diagnoses with specific treatment options and assumed accurate diagnosis. This may not accurately reflect the quality of care for all services provided. Additionally, comparison of MC data with historical controls can be confounded by other temporal changes that may have impacted health seeking behavior, but this was mitigated through the concurrent control clinic comparisons.

Ethical considerations

For focus group discussions, consent of adult men (age 18 and above) was written. No consent was needed from men subsequently attending MCs as all services provided are standard services available and approved by the Kenyan Ministry of Health. However, for patient privacy, patient names or other identifiable information were never recorded.

The protocol was approved by the Columbia University Institutional Review Board under protocol numbers IRB-AAAM0256 and AAAO2750. The study was also approved in Kenya by the Office of the President/Ministry of Interior and Coordination of National Government under reference number CORR 3\R\5\att\200.

Conclusion

This research shows that an intervention focusing specifically on men as health-seeking agents in their own right, instead of targeting men as part of a health package geared toward their female partners and children, can successfully lead to increased male attendance and return visits. Creating an enabling environment for men at health centers as this study did can therefore improve uptake of preventive care. The Male Clinics intervention successfully engaged men in regular check-ups despite the socially-constructed barriers of gender norms which paint care-seeking as feminine.

Whereas a woman’s health-seeking behavior might be triggered by a key life event such as childbirth, men do not have an equivalent event that would initiate a defined interaction with the health system. Standardizing the concept of Male Clinics in low-income countries could be an effective way to (re)connect men with health services. In the many contexts where there is a financial barrier to providing free care to all men, Ministries of Health, particularly in countries where men rarely seek care, may consider designing a specific life-defining moment where every man should visit a health center and the care given would also be free, as it is during MCs. This could be when men reach a specific age or at the birth of every one of his children. This would provide the benefits of MCs in that it would increase the uptake of preventive care, and thus significantly limit the funding required.

Supporting information

S1 Appendix. Male Clinics consultation form.

This is the form that was filled out by Male Clinics staff at each patient visit.

(DOCX)

S2 Appendix. Interview guide.

This is the interview guide used for focus group discussions.

(PDF)

S3 Appendix. Focus group questionnaire.

This is the questionnaire used during focus group discussions.

(PDF)

S4 Appendix. Consent form.

This is the consent form used to recruit patients for the study.

(PDF)

S5 Appendix. Code book.

This is the code book describing all the codes from the dataset.

(DOCX)

S1 Dataset. Male Clinics data_aggregation.

This is the entire dataset for the Male Clinics study.

(XLSX)

Data Availability

The anonymized data supporting the study is available within the paper and its Supporting Information files.

Funding Statement

Research funded by UNAIDS (https://www.unaids.org/en) under grants PG005551 (received by YBA) and P005210 (received by YBA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. For the research reported in this publication, IM was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number T32AI114398. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

References

  • 1.Promundo and UNFPA. Strengthening CSO-Government Partnerships to Scale Up Approaches to Engaging Men and Boys for Gender Equality and SRHR: A Tool for Action. Washington, DC, New York: Promundo-US, UNFPA; 2016. [Google Scholar]
  • 2.Aluisio A, Richardson BA, Bosire R, John-Stewart G, Mbori-Ngacha D, Farquhar C. Male antenatal attendance and HIV testing are associated with decreased infant HIV infection and increased HIV-free survival. Journal of acquired immune deficiency syndromes (1999). 2011;56(1):76–82. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Farquhar C, Kiarie JN, Richardson BA, Kabura MN, John FN, Nduati RW, et al. Antenatal couple counseling increases uptake of interventions to prevent HIV-1 transmission. Journal of acquired immune deficiency syndromes (1999). 2004;37(5):1620–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Mak J, Mayhew SH, von Maercker A, Integra Research Team IR, Colombini M. Men's use of sexual health and HIV services in Swaziland: a mixed methods study. Sexual health. 2016;13(3):265–74. 10.1071/SH15244 [DOI] [PubMed] [Google Scholar]
  • 5.Theuring S, Mbezi P, Luvanda H, Jordan-Harder B, Kunz A, Harms G. Male involvement in PMTCT services in Mbeya Region, Tanzania. AIDS and behavior. 2009;13 Suppl 1:92–102. [DOI] [PubMed] [Google Scholar]
  • 6.Msuya SE, Mbizvo EM, Hussain A, Uriyo J, Sam NE, Stray-Pedersen B. Low male partner participation in antenatal HIV counselling and testing in northern Tanzania: implications for preventive programs. AIDS care. 2008;20(6):700–9. 10.1080/09540120701687059 [DOI] [PubMed] [Google Scholar]
  • 7.Becker S, Mlay R, Schwandt HM, Lyamuya E. Comparing couples' and individual voluntary counseling and testing for HIV at antenatal clinics in Tanzania: a randomized trial. AIDS and behavior. 2010;14(3):558–66. 10.1007/s10461-009-9607-1 [DOI] [PubMed] [Google Scholar]
  • 8.John FN, Farquhar C, Kiarie JN, Kabura MN, John-Stewart GC. Cost effectiveness of couple counselling to enhance infant HIV-1 prevention. International journal of STD & AIDS. 2008;19(6):406–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Manjate Cuco RM, Munguambe K, Bique Osman N, Degomme O, Temmerman M, Sidat MM. Male partners' involvement in prevention of mother-to-child HIV transmission in sub-Saharan Africa: A systematic review. SAHARA J: journal of Social Aspects of HIV/AIDS Research Alliance. 2015;12:87–105. [DOI] [PubMed] [Google Scholar]
  • 10.Audet CM, Blevins M, Chire YM, Aliyu MH, Vaz LME, Antonio E, et al. Engagement of Men in Antenatal Care Services: Increased HIV Testing and Treatment Uptake in a Community Participatory Action Program in Mozambique. AIDS and Behavior. 2016;20(9):2090–100. 10.1007/s10461-016-1341-x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Barker G, Ricardo C, Nascimento M, Olukoya A, Santos C. Questioning gender norms with men to improve health outcomes: evidence of impact. Global public health. 2010;5(5):539–53. 10.1080/17441690902942464 [DOI] [PubMed] [Google Scholar]
  • 12.Camlin CS, Ssemmondo E, Chamie G, El Ayadi AM, Kwarisiima D, Sang N, et al. Men "missing" from population-based HIV testing: insights from qualitative research. AIDS care. 2016;28 Suppl 3:67–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Courtenay WH. Constructions of masculinity and their influence on men's well-being: a theory of gender and health. Social Science & Medicine. 2000;50(10):1385–401. [DOI] [PubMed] [Google Scholar]
  • 14.Addis ME, Mahalik JR. Men, masculinity, and the contexts of help seeking. American Psychologist. 2003;58(1):5–14. 10.1037/0003-066x.58.1.5 [DOI] [PubMed] [Google Scholar]
  • 15.World Health Organization. Engaging men and boys in changing gender-based inequity in health: Evidence from programme interventions. Geneva; 2007.
  • 16.van Loenen T, van den Berg MJ, Faber MJ, Westert GP. Propensity to seek healthcare in different healthcare systems: analysis of patient data in 34 countries. BMC Health Services Research. 2015;15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Haskew J, Turner K, Rø G, Ho A, Kimanga D, Sharif S. Stage of HIV presentation at initial clinic visit following a community-based HIV testing campaign in rural Kenya. BMC Public Health. 2015;15(1):16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Millennium Villages Project [Available from: http://millenniumvillages.org/the-villages/sauri-kenya/].
  • 19.Jivetti BA. Exploring the Impact of the Millennium Village Promise on Community Networks: The Case of Sauri Millennium Village in Western Kenya. Columbia, Missouri: University of Missouri; 2012. [Google Scholar]
  • 20.Population Estimates-Siaya County. 2017.
  • 21.Baker P, Dworkin SL, Tong S, Banks I, Shand T, Yamey G. The men’s health gap: men must be included in the global health equity agenda. Bulletin of the World Health Organization. 2014;92(8):618–20. 10.2471/BLT.13.132795 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Hardee K, Croce-Galis M, Gay J. Are men well served by family planning programs? Reproductive Health. 2017;14(1):14 10.1186/s12978-017-0278-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Mmari K, Oseni O, Fatusi AO. STI Treatment-Seeking Behaviors Among Youth in Nigeria: Are There Gender Differences? International Perspectives on Sexual and Reproductive Health. 2010;36(2):72–9. 10.1363/ipsrh.36.072.10 [DOI] [PubMed] [Google Scholar]
  • 24.Voeten HACM, O’Hara HB, Kusimba J, Otido JM, Ndinya-Achola JO, Bwayo JJ, et al. Gender Differences in Health Care-Seeking Behavior for Sexually Transmitted Diseases: A Population-Based Study in Nairobi, Kenya. Sexually Transmitted Diseases. 2004;31(5):265–72. 10.1097/01.olq.0000124610.65396.52 [DOI] [PubMed] [Google Scholar]
  • 25.Mak J, Mayhew SH, Maercker Av, Colombini IRT, Manuela. Men's use of sexual health and HIV services in Swaziland: a mixed methods study. Sexual Health (Online). 2016;13(3):265–74. [DOI] [PubMed] [Google Scholar]
  • 26.Springer KW, Mouzon DM. "Macho Men" and Preventive Health Care: Implications for Older Men in Different Social Classes. Journal of Health and Social Behavior. 2011;52(2):212–27. 10.1177/0022146510393972 [DOI] [PubMed] [Google Scholar]
  • 27.Ukwaja KN, Alobu I, Nweke CO, Onyenwe EC. Healthcare-seeking behavior, treatment delays and its determinants among pulmonary tuberculosis patients in rural Nigeria: a cross-sectional study. BMC Health Services Research. 2013;13(1):25. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.90-90-90: An ambitious treatment target to help end the AIDS epidemic. Geneva, Switzerland: UNAIDS; 2014 October. Report No.: JC2684.
  • 29.Kenya Health Workforce Report: The Status of Healthcare Professionals in Kenya, 2015. Nairobi, Kenya: Kenya Ministry of Health; 2016. [Google Scholar]

Decision Letter 0

Kwasi Torpey

Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

7 Aug 2019

PONE-D-19-16765

The impact of “male clinics” on health-seeking behaviors of adult men in rural Kenya

PLOS ONE

Dear Dr Yanis Ben Amor ,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by 30th Sept 2019. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Kwasi Torpey, MD PhD MPH

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent of the focus group/interview part of your study. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information

3. Please include a copy of the interview guide used in the study, in both the original language and English, as Supporting Information, or include a citation if it has been published previously.

4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is an important study as most health services globally tend not to focus on men and worse so in low resource settings yet men need to be empowered and enabled to use services.

The design is sound and the literature reviewed shows the gaps that exit in in this discipline.

The statistical analysis that was conducted was appropriate and answered what the researcher set out to do.

Lines 231-236 and table 5 : Can the researchers clarify their definition of RTI. Pneumonia and pleurisy are these not RTIs.

Table 5: UTIs and STIs. Can the researchers clarify how these were differentiated and confirmed ( laboratory or syndromic).

Line 248: PITC was the second most common test done. In which facilities? Would be helpful to report comparison results from the intervention, comparison and historic data.

Quality of care section. Line 251

This is a very important section in this study. The researchers can enrich the paper by elaborating this section to show if there were statistical differences on this outcome for the intervention and comparison sites.

Service utilization:

Were the opening hours the same in the intervention and control sites? Can this be specified.

Conclusion section Line 356

Lines 364-367: The recommendations made in this section are not backed by findings from the study. Researchers need to modify this section to be more explicit in line with the study findings.

Reviewer #2: The manuscript is well written and it fills an important gap in the literature. The multi-disease approach to men’s health is an important area to further explore as health services in some African countries tend to be siloed due to donor priorities. The paper highlights the benefit of a general health approach (rather than a disease-based approach) to engage men in health services.

Specific comments/suggestions

1. Table 5 seems to lump HIV diagnosis with STIs. Is it possible to separate them? This would be helpful for those in the HIV field. Indeed, engaging men in HIV services has been deemed as a blind spot in the HIV response. It would be helpful if more details on HIV diagnosis are included in the paper.

2. In the section of reproductive health, I am not sure if it makes sense to compare results from the treatment group to “all” control groups, especially since I am assuming this would include the historical control group (line 244-245). It may be better to compare to separate control groups.

3. It is well established that men’s health seeking behaviors are influenced by masculinity norms. This comes out tangentially in the paper in lines 271-273. The paper highlights cost of services, distance to the facility, cost of transport, and quality of services as the main barriers. While this may have been the main barriers cited by men, it is important not to discount the gender norms issues cited in line 271-273. I suggest finding a way to make sure those are not lost in the manuscript.

4. Another important aspect in the manuscript is that the intervention was successful in engaging men in regular check ups (compared to controls). This also needs to be highlighted in the discussion and conclusion.

5. For circumcision services, it may be helpful to indicate if the sites are high volume or low volume sites and provide the range of clients. Typically, in high volume sites hundreds of boys/men may access VMMC services. That clarification is important to understand the context

6. The age range of the men participants is important. Also, if you can provide any short table with socio-demographic characteristics that would be a bonus to help the reader understand who are the men who accessed MC.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Maria A. Carrasco

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2019 Nov 21;14(11):e0224749. doi: 10.1371/journal.pone.0224749.r002

Author response to Decision Letter 0


30 Sep 2019

Re: Response to reviewers for the submission titled, “The impact of ‘male clinics’ on health-seeking behaviors of adult men in rural Kenya”

September 30, 2019

To the Reviewers and Editors,

Thank you for your careful review of our submission titled, “The impact of ‘male clinics’ on health-seeking behaviors of adult men in rural Kenya.” Please find our point-by-point responses below.

JOURNAL REQUIREMENTS

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Our manuscript meets PLOS ONE’s style requirements, including those for file naming.

2. Please provide additional details regarding participant consent of the focus group/interview part of your study. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information

For the focus groups discussions, consent of adult men (age 18 and above) was written. This was added in the Ethical Considerations section (line 366).

3. Please include a copy of the interview guide used in the study, in both the original language and English, as Supporting Information, or include a citation if it has been published previously.

A copy of the interview guide (S2 Appendix Interview Guide), questionnaires of the focus groups (S3 Appendix Focus Group Questionnaire) and Consent form (S4 Appendix Consent Form) have been included as supplementary documents.

4. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

We have uploaded the minimal anonymized data set (S5 Appendix Male Clinics data and S6 Appendix Code Book)

Consent for publication of raw data was not obtained but dataset is fully anonymous in a manner that can easily be verified by any user of the dataset. Publication of the dataset clearly and obviously presents minimal risk to confidentiality of study participants. It was not possible to obtain consent from participants because the quantitative data was not collected from individuals but from clinic registers and the unit of analysis is a clinic visit not a patient.

REVIEWER 1:

Lines 231-236 and table 5: Can the researchers clarify their definition of RTI. Pneumonia and pleurisy are these not RTIs.

We thank the reviewer for spotting this. Pneumonia and asthma are Lower Respiratory Tract Infections (LRTI). To prevent confusion, we removed in tables 1 and 5 the mention of RTI and specified URTI and LRTI, where appropriate.

Table 5: UTIs and STIs. Can the researchers clarify how these were differentiated and confirmed (laboratory or syndromic).

The diagnosis of UTIs and STIs was syndromic, except specifically for syphilis where the Venereal Disease Research Laboratory (VDRL) test was used.

Line 248: PITC was the second most common test done. In which facilities? Would be helpful to report comparison results from the intervention, comparison and historic data.

PITC was the second most common test offered in intervention clinics across the board except for Ramula where it was the most common. Tests offered were only recorded in the intervention group so we cannot compare across groups. We thus did the assessment in the intervention group only and found that there was no statistically significant difference in PITC offering by intervention clinic (p= 0.1152). A clarification on this point has been added to the “Reproductive health services” section (lines 259-262).

Quality of care section. Line 251

This is a very important section in this study. The researchers can enrich the paper by elaborating this section to show if there were statistical differences on this outcome for the intervention and comparison sites.

We did not disaggregate the quality of care outcome by control group because there was such a small difference amongst them. Instead we conducted the analysis by combining all control groups. More detail has been added to this effect in the “Quality of care” section, lines 267-269. For the reviewers’ reference, the proportion of correct treatments by diagnosis was 90.91% in the “concurrent control at different clinics” group, 93.3% in the historic control group, and 90.94% in the “concurrent control at intervention clinics” group.

Service utilization:

Were the opening hours the same in the intervention and control sites? Can this be specified.

Yes, the hours were the same. This has been added to the “Evaluation design” portion on line 150.

Conclusion section Line 356

Lines 364-367: The recommendations made in this section are not backed by findings from the study. Researchers need to modify this section to be more explicit in line with the study findings.

We thank the reviewer for this suggestion. We have rewritten this section to make it more in line with our findings about engaging men in preventive care. This is reflected in lines 382-391.

REVIEWER 2:

The manuscript is well written and it fills an important gap in the literature. The multi-disease approach to men’s health is an important area to further explore as health services in some African countries tend to be siloed due to donor priorities. The paper highlights the benefit of a general health approach (rather than a disease-based approach) to engage men in health services.

Thank you for your review and this comment. The reviewer’s last sentence here has been added to the introduction, lines 86-87.

Specific comments/suggestions

1. Table 5 seems to lump HIV diagnosis with STIs. Is it possible to separate them? This would be helpful for those in the HIV field. Indeed, engaging men in HIV services has been deemed as a blind spot in the HIV response. It would be helpful if more details on HIV diagnosis are included in the paper.

Thank you for this suggestion. Table 5 shows positive diagnoses for each condition, as opposed to the number of patients tested for the condition. For example, there were 11 patients diagnosed with diabetes in the intervention group. The number of patients tested for diabetes would be much higher. We did not record a patient’s positive or negative HIV status, rather we tracked whether a patient was aware of his HIV status. As a result, in Table 5, STI does not include HIV. Therefore, we are unable to disaggregate STI from HIV in the results or to report more thoroughly on HIV diagnoses of MC participants. However, we did record whether PITC was administered when a patient was unaware of his status, and that result is reported lines 279-281.

2. In the section of reproductive health, I am not sure if it makes sense to compare results from the treatment group to “all” control groups, especially since I am assuming this would include the historical control group (line 244-245). It may be better to compare to separate control groups.

We have done an assessment of STI diagnosis by individual groups (as opposed to combined control groups). We found no statistically significant difference in STI diagnosis by intervention or control group (p = 0.5043). The proportion of visits resulting in an STI diagnosis by group was added to the "Reproductive health services" section, lines 252-255.

3. It is well established that men’s health seeking behaviors are influenced by masculinity norms. This comes out tangentially in the paper in lines 271-273. The paper highlights cost of services, distance to the facility, cost of transport, and quality of services as the main barriers. While this may have been the main barriers cited by men, it is important not to discount the gender norms issues cited in line 271-273. I suggest finding a way to make sure those are not lost in the manuscript.

We thank you for this suggestion. Further mention of this has been added to the conclusion, lines 379-381.

4. Another important aspect in the manuscript is that the intervention was successful in engaging men in regular check ups (compared to controls). This also needs to be highlighted in the discussion and conclusion.

This has been highlighted in the discussion, lines 298-302 and conclusion, lines 379-381.

5. For circumcision services, it may be helpful to indicate if the sites are high volume or low volume sites and provide the range of clients. Typically, in high volume sites hundreds of boys/men may access VMMC services. That clarification is important to understand the context

Information about how VMMC played a role in the context of male clinics has been added to the Study area section, lines 102-104.

6. The age range of the men participants is important. Also, if you can provide any short table with socio-demographic characteristics that would be a bonus to help the reader understand who are the men who accessed MC.

Because age was the only demographic variable measured, we did not add a table. We added a more detailed description of men who accessed MC in the “demographics” section, lines 217-219.

Attachment

Submitted filename: Response to reviewers_MC_Sept 30.docx

Decision Letter 1

Kwasi Torpey

22 Oct 2019

The impact of “male clinics” on health-seeking behaviors of adult men in rural Kenya

PONE-D-19-16765R1

Dear Dr. Yanis Ben Amor,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

With kind regards,

Kwasi Torpey, MD PhD MPH

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Kwasi Torpey

7 Nov 2019

PONE-D-19-16765R1

The impact of “male clinics” on health-seeking behaviors of adult men in rural Kenya

Dear Dr. Ben Amor:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

For any other questions or concerns, please email plosone@plos.org.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Kwasi Torpey

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Appendix. Male Clinics consultation form.

    This is the form that was filled out by Male Clinics staff at each patient visit.

    (DOCX)

    S2 Appendix. Interview guide.

    This is the interview guide used for focus group discussions.

    (PDF)

    S3 Appendix. Focus group questionnaire.

    This is the questionnaire used during focus group discussions.

    (PDF)

    S4 Appendix. Consent form.

    This is the consent form used to recruit patients for the study.

    (PDF)

    S5 Appendix. Code book.

    This is the code book describing all the codes from the dataset.

    (DOCX)

    S1 Dataset. Male Clinics data_aggregation.

    This is the entire dataset for the Male Clinics study.

    (XLSX)

    Attachment

    Submitted filename: Response to reviewers_MC_Sept 30.docx

    Data Availability Statement

    The anonymized data supporting the study is available within the paper and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES